These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2799279)

  • 41. International Federation of Clinical Chemistry (IFCC). Scientific Committee, Analytical Section. Guidelines (1984) for listing specification spectrometers in clinical chemistry.
    Bechtler G; Haeckel R; Lappe H; Tausch W
    J Clin Chem Clin Biochem; 1984 Aug; 22(8):565-71. PubMed ID: 6491618
    [No Abstract]   [Full Text] [Related]  

  • 42. Regional quality assurance for the 1980's, current status and future directions.
    Lawson NS; Haven GT; Ross JW
    Am J Clin Pathol; 1980 Oct; 74(4 Suppl):552-9. PubMed ID: 7435447
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effects of drugs on laboratory results--still a problem of current interest].
    Daae LN
    Tidsskr Nor Laegeforen; 1996 Oct; 116(24):2872. PubMed ID: 8975399
    [No Abstract]   [Full Text] [Related]  

  • 44. Reference materials and reference measurement systems in laboratory medicine. Harmonization of nomenclature and definitions in reference measurement systems.
    Dybkaer R
    Eur J Clin Chem Clin Biochem; 1995 Dec; 33(12):995-8. PubMed ID: 8845435
    [TBL] [Abstract][Full Text] [Related]  

  • 45. International Federation of Clinical Chemistry, Scientific Committee, Analytical Section, Expert Panel on Instrumentation. (IFCC Document 1981 Stage 2, Draft 1; 1981-08-01 with a proposal for an IFCC recommendation) Provisional guidelines (1981) for listing specifications of flame emission spectrometers.
    Bechtler G; Epstein MS; Geary TD; Havemann W; Attoe P
    J Clin Chem Clin Biochem; 1982 Apr; 20(4):259-61. PubMed ID: 7077241
    [No Abstract]   [Full Text] [Related]  

  • 46. International Federation of Clinical Chemistry. Scientific Committee, Analytical Section. Expert Panel on Instrumentation. (IFCC Document 1981 Stage 2, Draft 1; 1981-08-01 with a proposal for an IFCC recommendation). Provisional guidelines (1981) for listing specifications of atomic absorption spectrometers.
    Epstein MS; Geary TD; Gower G; Tausch W; Mills KJ; Polt D
    J Clin Chem Clin Biochem; 1982 Apr; 20(4):263-6. PubMed ID: 7077242
    [No Abstract]   [Full Text] [Related]  

  • 47. Reference materials in clinical chemistry.
    Cali JP
    Fed Proc; 1975 Nov; 34(12):2123-6. PubMed ID: 1183614
    [No Abstract]   [Full Text] [Related]  

  • 48. Clinical and professional reference guides. Critical values for therapeutic drug levels.
    Millar S
    MLO Med Lab Obs; 2001 Aug; 33(8 Suppl):15. PubMed ID: 11571829
    [No Abstract]   [Full Text] [Related]  

  • 49. [Practical considerations in attributing drug effects: 1 000 cases].
    Begaud B; Haramburu F; Père JC; Dangoumau J
    Therapie; 1982; 37(4):415-20. PubMed ID: 7135323
    [No Abstract]   [Full Text] [Related]  

  • 50. [Role of analytical chemistry in the pharmacy of the 21st Century].
    Görög S
    Acta Pharm Hung; 2001 Oct; 71(3):337-43. PubMed ID: 11961903
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Research in the field of clinical pharmacology in the USSR].
    Lakin KM; Makarov VA; Novikova NV
    Farmakol Toksikol; 1982; 45(3):5-12. PubMed ID: 7047211
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Ring experiments in clinical chemistry].
    Stamm D
    Schweiz Med Wochenschr; 1971 Mar; 101(12):429-37. PubMed ID: 5559406
    [No Abstract]   [Full Text] [Related]  

  • 53. [Introduction to medicinal chemistry. Comment on the rational and empirical approach].
    Jensen CL
    Dan Tidsskr Farm; 1966 Nov; 40(11):279-305. PubMed ID: 5342079
    [No Abstract]   [Full Text] [Related]  

  • 54. [The Theriaque database and information on side effects of drugs].
    Amiel ML; Husson MC
    Therapie; 1994; 49(5):455-8. PubMed ID: 7855764
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Data banks.
    Tryding N; Nachbaur J; Galteau MM
    Ann Biol Clin (Paris); 1986; 44(1):70-6. PubMed ID: 3706836
    [No Abstract]   [Full Text] [Related]  

  • 56. Bioanalysis of complex clinical samples - considerations on analytical variability: some thoughts to ponder.
    Srinivas NR
    Biomed Chromatogr; 2011 Jun; 25(6):734-6. PubMed ID: 21387352
    [No Abstract]   [Full Text] [Related]  

  • 57. European Bioanalysis Forum and the way forward towards harmonized regulations.
    Lausecker B; van Amsterdam P; Brudny-Kloeppel M; Luedtke S; Timmerman P
    Bioanalysis; 2009 Aug; 1(5):873-5. PubMed ID: 21083056
    [No Abstract]   [Full Text] [Related]  

  • 58. [Pharmaceutical aspects of drug side effects].
    Speiser P
    Ther Umsch; 1993 Jan; 50(1):37-41. PubMed ID: 8378865
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Microcomputerized data bank of nephrotoxic drugs at the Paris-Saint Antoine Regional Drug Monitoring Center].
    Hamel JD; Biour M; Cheymol G
    Therapie; 1986; 41(5):327-9. PubMed ID: 3810519
    [No Abstract]   [Full Text] [Related]  

  • 60. The significance of properly designed pre-clinical studies in the clinical evaluation of new drugs.
    Garrett ER
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):6-20. PubMed ID: 4924331
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.